1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Soliris: new trials by email Literature Review of Soliris trials Research Report on Soliris
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ravulizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria Currently Treated With High-Dose Eculizumab Eculizumab, Ravulizumab - Paroxysmal Nocturnal Hemoglobinuria | Phase 4 | Completed | Alexion Pharmaceuticals, Inc. | 18 | 2021-04-14 | 2024-09-05 |
Hemoglobinuria, Paroxysmal (1)
Alexion Pharmaceuticals, Inc. (1)
United Kingdom (1)
2019 (1)